Please login to the form below
Bayer's Eylea cleared for wider use in Europe
Macular oedema treatment reached €759m in sales last year
Novartis divests cancer drugs to bring GSK deal to completion
Firms also collaborating on joint consumer health venture
Amgen's Kyprolis tops Velcade in myeloma trial
Amgen hoping to topple Takeda’s $2bn a year drug
Sanofi’s Lantus follow-up nears European approval
CHMP backing for Toujeo follows hot on the heels of its US approval by the FDA
Greater Manchester to control its share of the NHS budget
The north-west English region accounts for 5% of the country's health spending
Jinarc backed for European approval in rare kidney disease
Positive opinion for Otsuka comes just before rare disease awareness day
UCB boosted by core medicines growth
Firm’s new chief executive 'excited' by his company’s next batch of medicines
Sovaldi-Daklinza combo cures hep C in co-infected HIV patients
Phase III trial of BMS and Gilead antivirals cured 97% of patients
Gilead's Sovaldi wins NICE approval but faces access delay
The Institute also recommends Janssen's hepatitis C drug Olysio
Does 'trust leadership' feature in your strategy?
Pharma companies wanting to be more patient-focused will need to develop their people skills
-
2015: A year of promise and connectivityHow could technology impact healthcare in this year and what will be the key trends to follow?
-
Future gazing: What does 2015 hold for NICE?Undermined by the CDF, the Institute is set to face a number of challenges this year
-
Sanofi gets green light for Lantus follow-up ToujeoOnce-daily basal insulin gains FDA approval for diabetes
-
Actavis gets FDA nod for new antibioticAvycaz is the fifth antibiotic to gain US approval in recent months
-
BMS buys immunotherapy specialist Flexus in $1.2bn dealAnd signs new cancer research partnership with Rigel
-
Shire boosts orphan drug pipeline with Meritage Pharma dealFirm will also acquire global rights to Meritage’s phase III OBS compound
-
Remicade biosimilars hit European marketHospira and Mundipharma begin marketing their version of the blockbuster drug
-
Takeda grows in Turkey with Neutec subsidiary acquisitionWill acquire Toplam Kalite for up to 300m Turkish lira
-
US lawmaker pushes for drug price transparency If passed a new Bill would demand pharma show how product price tags are worked out
Latest appointments
-
Ex Sanofi boss joins Boston start-upChris Viehbacher joins other industry veterans as the newest board member of PureTech
-
UCB CEO elected to the Ministerial Industry Strategy GroupJean-Christophe Tellier assumed the role of CEO on January 1
-
Werner Baumann to replace Brandicourt at BayerWill assume the role of chairman after the former boss jumped ship to Sanofi
-
Kymab names Anne Hyland as chief financial officerHyland joins from BBI Diagnostics
-
Everyday Health appoints PHCG presidentMichael du Toit to take up same position
Featured jobs
- Business Unit Director – Consumer Healthcare Advertising – South...
-
Very lucrative remuneration on offer
- FREELANCE!! Account Manager / Senior Account Manager – TOP 5 Hea...
-
VERY COMPETITIVE DAY RATE
- Associate Project Director – Meetings Management - Reading, Berk...
-
Competitive + excellent benefits
- Account Executive and Senior Account Executive NEEDED for FUN &...
-
Bonus + Benefits
- Director – Client Engagement – Brand Team - Reading, Berkshire...
-
Senior level salary + comprehensive benefits
- AM or Senior Account Manager – Digital – Healthcare Advertising ...
-
EXTENSIVE PACKAGE AVAILABLE
- Senior Medical Writer
-
Competitive Salary Offered
DGH Recruitment
- Experienced Medical Writer MILAN – ITALY – Medical Education – R...
-
Excellent Remuneration & Relocation Assistance
- Assistant Editor – Clinical Pharmacy: The Pharmaceutical Journal...
-
Competitive Salary Offered
- Healthcare PR Account Manager, Internal Communications
-
c£30-35,000 according to skills and experience
- Account Manager & Senior Account Manager – Medical Communica...
-
£33000 - £48000 + BONUS + BENEFITS
Subscribe to our email news alerts
- Indian generics firm GVK set to be hit with European sales ban
- England's Cancer Drugs Fund: Fixing a broken system
- Early win for Pfizer as Remicade biosimilar launches in West Europe
- Boehringer in breach over beer drinking, lederhosen presentation
- Pharma firms violate marketing regulations every week, claims study
- Advagraf shows survival increase for liver transplant patients
- Greater Manchester to control its share of the NHS budget from April
- Drivers of 2014′s Soaring Drug Approvals
- Jinarc backed for European approval in rare kidney disease
- UCB boosted by core medicines growth
- Sovaldi-Daklinza combo cures hep C in co-infected HIV patients
- Bayer's Eylea cleared for wider use in Europe
PMHub
Facilitate Ltd
Established in 2002, Facilitate is a global medical communications agency providing high-quality, creative services that focus on top-level opinion leader...
Latest intelligence
- Drivers of 2014′s Soaring Drug Approvals
- The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
- Russian innovation at the crossroads
- Despite improvements, investors face rising risks...
- E-detailing content wow factor in 2015
- Many companies are reporting that the iPad novelty has worn off and healthcare professionals are demanding more than just another animation presented on a mobile device. So what exactly are...
Quick links
